Tourmaline Bio (NASDAQ:TRML) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate Merger – TRML, PNFP, MRCC, and UNP
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AL, TRML, SOL on Behalf of Shareholders
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Tourmaline Bio, Inc. (NASDAQ: TRML)